← 產業報告目錄
Pharma 4.0 Market Size, Share & Trends Analysis Report By Technology (Cloud Computing, Artificial Intelligence, Big Data Analytics, Internet of Thing), By Application (Drug Discovery and Development, Clinical Trials, Manufacturing), By End-User (Pharmaceutical Companies, Biotechnology Companies, CROs and CMOs), Region And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-12頁數 180報告編號 INSIGHTACE-8e5159be48
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Pharma 4.0 Market on a global scale was estimated at USD 16.57 billion in 2024 and is anticipated to attain USD 87.03 billion by 2034, with a projected CAGR of 18.1% between 2025 and 2034.
Pharma 4.0 covers key industry insights & findings from the report:
Businesses in the life sciences as well as pharmaceutical industries stand to gain a great deal from pharma 4.0 implementation. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is propelled by rising healthcare spending, technological evolution, and the rising focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region anticipated to deliver the strongest growth trajectory through the forecast period, propelled by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Technologyology and Scope
1.1. Research Technologyology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pharma 4.0 Market Snapshot
Chapter 4. Global Pharma 4.0 Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Technology Estimates & Trend Analysis
5.1. By Technology, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Technology:
5.2.1. Cloud Computing
5.2.2. Artificial Intelligence (AI)
5.2.3. Big Data Analytics
5.2.4. Internet of Things (IoT)
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
6.2.1. Drug Discovery and Development
6.2.2. Clinical Trials
6.2.3. Manufacturing
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
7.2.1. Pharmaceutical Companies
7.2.2. Biotechnology Companies
7.2.3. CROs and CMOs
Chapter 8. Pharma 4.0 Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Pharma 4.0 Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
8.1.2. North America Pharma 4.0 Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.1.3. North America Pharma 4.0 Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
8.1.4. North America Pharma 4.0 Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Pharma 4.0 Market revenue (US$ Million) By Technology, 2021-2034
8.2.2. Europe Pharma 4.0 Market revenue (US$ Million) By Application, 2021-2034
8.2.3. Europe Pharma 4.0 Market revenue (US$ Million) By End User, 2021-2034
8.2.4. Europe Pharma 4.0 Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Pharma 4.0 Market revenue (US$ Million) By Technology, 2021-2034
8.3.2. Asia Pacific Pharma 4.0 Market revenue (US$ Million) By Application, 2021-2034
8.3.3. Asia Pacific Pharma 4.0 Market revenue (US$ Million) By End User, 2021-2034
8.3.4. Asia Pacific Pharma 4.0 Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Pharma 4.0 Market revenue (US$ Million) By Technology, (US$ Million) 2021-2034
8.4.2. Latin America Pharma 4.0 Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.4.3. Latin America Pharma 4.0 Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
8.4.4. Latin America Pharma 4.0 Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Pharma 4.0 Market revenue (US$ Million) By Technology, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Pharma 4.0 Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.5.3. Middle East & Africa Pharma 4.0 Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
8.5.4. Middle East & Africa Pharma 4.0 Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Microsoft Corporation
9.2.2. Oracle Corporation
9.2.3. ABB
9.2.4. Honeywell International Inc.
9.2.5. Cisco Systems, Inc.
9.2.6. Siemens Healthcare GmbH
9.2.7. GE Healthcare
9.2.8. IBM Corporation
9.2.9. Amazon Web Services, Inc.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們